Steven L. Carroll, MD, PhD, FASCP, FCAP
Chair of the Department of Pathology and Laboratory Medicine
Gordon R. Hennigar, Jr., MD, Endowed Chair in Pathology
Director of the South Carolina Alzheimer’s Disease Research Center
Director of the Carroll A. Campbell Jr. Neuropathology Laboratory
Steven L. Carroll, MD, PhD, FASCP, FCAP is Professor and Chair of the Department of Pathology and Laboratory Medicine at the Medical University of South Carolina (MUSC), where he holds the Gordon R. Hennigar, Jr., MD, Endowed Chair in Pathology. Dr. Carroll is board certified by the American Board of Pathology in Anatomic Pathology and Neuropathology. Dr. Carroll’s research program, which is funded by the National Institutes of Health, the Department of Defense and the Children’s Tumor Foundation, studies the role that the growth factor neuregulin-1 and its erbB receptors plays in the pathogenesis of neurofibromatosis-associated peripheral nerve sheath tumors and neurodegenerative diseases.
At MUSC Hollings Cancer Center, Dr. Carroll serves as Director of the Biorepository & Tissue Analysis Shared Resource. Dr. Carroll also serves as the Director of the South Carolina Alzheimer’s Disease Research Center and the Carroll A. Campbell Jr. Neuropathology Laboratory (Brain Bank). Dr. Carroll is an Associate Editor for the American Journal of Pathology and the Journal of Neuropathology and Experimental Neurology and is a member of the Editorial Board for Neuro-Oncology. He is a founding member of the international Down Syndrome Biobanking Consortium, which includes MUSC, the Barrow Neurological Institute, the University of Colorado Denver, the University of California Irvine, New York University, the Sant Pau Memory Unit (Barcelona, Spain), Cambridge University (UK), the Karolinska Institutet (Stockholm, Sweden) and the University of Calcutta (India). Working with the Children’s Tumor Foundation, Dr. Carroll has established a national network to bank biospecimens from autopsied patients who had neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2) and schwannomatosis.
Dr. Carroll received his B.S. degree in Vertebrate Zoology, Chemistry and Anthropology from the University of Memphis in 1981. He then attended Baylor College of Medicine, receiving his Ph.D. in Cell Biology in 1986 and his M.D. in 1988. Dr. Carroll’s postdoctoral research fellowship, Anatomic Pathology Residency and Neuropathology Fellowship were performed at the Washington University in St. Louis School of Medicine (1988-1994). Prior to his arrival at MUSC in 2014, Dr. Carroll was Professor of Pathology, Neurobiology and Cell Biology at the University of Alabama at Birmingham (UAB) and the Director of the UAB Division of Neuropathology. While at UAB, Dr. Carroll served as an attending neuropathologist at the University of Alabama Hospital, the Birmingham VA, UAB Highlands Hospital and Alabama Children’s Hospital. He was a Scientist in the UAB Alzheimer’s Disease Research Center, the Mental Retardation Research Center, the Center for Aging, the Center for Glial Biology in Medicine, the Civitan International Research Center and the Center for Neurodegeneration and Experimental Therapeutics as well as being as a Member of the Comprehensive Neuroscience Center and a Senior Scientist in the UAB Comprehensive Cancer Center.